Search Results 2091-2100 of 16085 for Epilepsy (Partial Onset)
dysfunctions, pregnancy, Raynaud's disease, epilepsy, severe mental disorders, chronic pain conditions, or diseases producing neuropathic pain; Participants ...
December 6, 2023. Consumer Health: Epilepsy in children. Laurel Kelly ... 'Dogtor' and doctor return joy to boy with severe epilepsy. Susan Barber ...
This is a multicenter, open-label trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pre-capillary pulmonary hypertension (PH) ...
Mayo Clinic hematologists, hematopathologists, radiation oncologists and transplant specialists work together to ensure all of your individual needs are ...
Confirmed COVID-19: the Baseline visit must be at least 14 days from onset of signs/symptoms or positive SARS-CoV-2 test, symptomatic subjects must have ...
Research. Mayo Clinic experts research and test new treatments for focal segmental glomerulosclerosis (FSGS) through the Mayo Nephrology Collaborative Group. As ...
The purpose of this study is to evaluate whether or not the diaphragm and abdominal muscle thickness determine the duration of mechanical ventilation in adult ...
... partial response [PR]), overall survival (OS), duration of response (DOR), time to progression (TTP). ... The purpose of this study is to evaluate the safety, ...
... focal cartilage defects of the hip. The secondary objectives of the study are to assess the effect of RECLAIM on pain and function in the target hip, and to ...
... duration of the study and no dose adjustment is made during the duration of the study. Willing to follow a food elimination diet. Exclusion Criteria: Cannot ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.